Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP13-512J5.1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | ZNF691 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | KBTBD7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | C6orf203 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | CTXN2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CACNA1C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RNF146 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PKD1L3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | CRYBA2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | AC127070.1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |